MedTrace Logo

Impact of Enhanced External Counterpulsation (EECP) on Cardiac Force Index

NCT05080023 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2022-02-23

No results posted yet for this study

Summary

Regular exercise can prevent cardiovascular disease, but there is also a risk of sudden cardiac death. Exercise-related sudden death often occurs unconsciously and there is no relevant monitoring mechanism. The patent of the Cardiac Force Index (CFI), invented by Professor Chu, is a method to detect the state of cardiac motion. Recent studies have confirmed Enhanced External Counterpulsation (EECP) can increase cardiopulmonary fitness and maximal oxygen consumption. Our aim is to investigate the differences and effects of CFI between two groups with and without 4 weeks of EECP intervention, therefore, to find out the relationship between CFI and maximum oxygen consumption (VO2max).

Methods: A pre and post-test control group was designed. A total of 53 military students (33 males and 20 females) were recruited and divided into intervention and control groups. A 2000-meter running and maximum oxygen consumption tests were performed pre and post-test. The intervention group was conducted a 4 week (3 times per week/30 minutes) EECP intervention.

Conditions

  • Enhanced External Counterpulsation (EECP)
  • Cardiac Output
  • Cardiac Force Index

Interventions

DEVICE

Enhanced External Counterpulsation (EECP)

Enhanced External Counterpulsation (EECP)

Sponsors & Collaborators

  • Dr. Chiang, Shang-lin

    collaborator UNKNOWN

  • Dr. Liang-Cheng Chen

    collaborator UNKNOWN

  • Chi-Ming Chu

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-22
Primary Completion
2022-12-31
Completion
2023-12-31
FDA Device
Yes

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05080023 on ClinicalTrials.gov